1.Imaging Techniques for Endocrine Diseases: Current and Future Directions.
Korean Journal of Endocrine Surgery 2001;1(1):39-50
No abstract available.
Endocrine System Diseases*
2.Slow virus and endocrine disease.
Yong Sun KIM ; Eun Kyoung CHOI ; I Carp RICHAR
Journal of Korean Society of Endocrinology 1993;8(1):6-14
No abstract available.
Endocrine System Diseases*
3.Anesthetic for Endocrine Diseases.
Korean Journal of Anesthesiology 1987;20(3):265-270
No abstract available.
Endocrine System Diseases*
4.Anesthetic Management for Pheochromoeytoma Removal - A case report .
Jun Seok GO ; Bong Il KIM ; Jin Woong PARK
Korean Journal of Anesthesiology 1980;13(4):432-436
Pheoehromocytoma is a kind of very rare endocrine disease and which is completely recovered by surgical resection of the tumor, but rapidly changing cardiovascular response to the cathecholamine during the anesthetic course and after removal of tumor make the anesthetic management difficulty. Various anesthetic agent can be used with their good and bad characteristics successfully if the pathophysiology of the disease and pharmacology of the drugs are kept in mind. We have experienced successful anesthetic management for pheocromocytoma removal using halothane-N2O-O2, and muscle relaxant and cardiovascular change was supported by pentolamine (Regitine), Propranolol(Inderal), and Levophed.
Endocrine System Diseases
;
Norepinephrine
;
Pharmacology
5.Nuclear Medicine for Endocrine Diseases: Current and Future Directions.
Korean Journal of Endocrine Surgery 2001;1(1):30-38
No abstract available.
Endocrine System Diseases*
;
Nuclear Medicine*
6.Endocrine disorders and the neurologic manifestations.
Annals of Pediatric Endocrinology & Metabolism 2014;19(4):184-190
The nervous system and the endocrine system are closely interrelated and both involved intimately in maintaining homeostasis. Endocrine dysfunctions may lead to various neurologic manifestations such as headache, myopathy, and acute encephalopathy including coma. It is important to recognize the neurologic signs and symptoms caused by the endocrine disorders while managing endocrine disorders. This article provides an overview of the neurologic manifestations found in various endocrine disorders that affect pediatric patients. It is valuable to think about 'endocrine disorder' as a cause of the neurologic manifestations. Early diagnosis and treatment of hormonal imbalance can rapidly relieve the neurologic symptoms. Better understanding of the interaction between the endocrine system and the nervous system, combined with the knowledge about the pathophysiology of the neurologic manifestations presented in the endocrine disorders might allow earlier diagnosis and better treatment of the endocrine disorders.
Child
;
Coma
;
Diagnosis
;
Early Diagnosis
;
Endocrine System
;
Endocrine System Diseases
;
Headache
;
Homeostasis
;
Humans
;
Muscular Diseases
;
Nervous System
;
Neurologic Manifestations*
7.A Case of Idiopathic Acanthosis Nigricans.
Ho Joo YOON ; Seung Il KIM ; Kyu Dock SHIN ; Poong Man LEE
Journal of the Korean Pediatric Society 1981;24(7):685-689
Acanthosis nigricans is characterized by hyperpigmented, velvety thickening of the skin of any part of the body and frequently associated with internal malignancy, endocrine diseases and obesity. In children, systemic abnormality rarely occur in associated with prepubertal Acanthosis nigricans. We experienced a case of idiopathic Acanthosis nigricans, and made a brief review of literatures.
Acanthosis Nigricans*
;
Child
;
Endocrine System Diseases
;
Humans
;
Obesity
;
Skin
8.Diagnosis and treatment of male testosterone deficiency.
National Journal of Andrology 2010;16(4):291-294
Testosterone, as the most important sex hormone of the male, plays a critical role in growth, development, reproduction, and maintenance of the functions of vital organs. Testosterone deficiency may lead to functional disorders in many organs or systems, which are collectively termed testosterone deficiency syndrome (TDS). TDS is a clinical and physiochemical syndrome resulted from ageing. It is recognized that the abnormally low level of testosterone is correlated with the male unhealthy status. As for the treatment of TDS, disputes exist over the necessity of testosterone supplement and the time to start the therapy, because the testosterone threshold that induces the clinical symptoms differs among different individuals and the symptoms are non-specific.
Endocrine System Diseases
;
diagnosis
;
therapy
;
Humans
;
Male
;
Testosterone
;
deficiency
9.Case Reports of Severe Coronary Artery Spasm Associated with Three Different Endocrine Hyperfunction.
Seung Hyun HONG ; Kyung Ae LEE ; Tae Sun PARK ; Hong Sun BAEK ; Heung Yong JIN ; Sung Yun LEE
Soonchunhyang Medical Science 2015;21(2):95-98
Disorders of the endocrine system including hormone hyperfunction and hypofunction have multiple effects on cardiovascular system. However, in clinical practice, there are many cases of delayed or overlooked diagnosis of underlying endocrine dysfunction in patients presenting chest pain or other cardiac symptoms. Herein, we report three cases of endocrine hyperfunction presenting as coronary spasm; Graves' hyperthyroidism, pheochromocytoma, and primary hyperparathyroidism. Chest pains disappear after treatment for these endocrine diseases. Endocrine hyperfunctions such as the three cases described above should be considered as possible diagnosis in patients with complaint of chest pain. High index of suspicion are needed.
Cardiovascular System
;
Chest Pain
;
Coronary Vessels*
;
Diagnosis
;
Endocrine System
;
Endocrine System Diseases
;
Humans
;
Hyperparathyroidism
;
Hyperparathyroidism, Primary
;
Hyperthyroidism
;
Pheochromocytoma
;
Spasm*
10.Childhood obesity and endocrine disrupting chemicals.
Annals of Pediatric Endocrinology & Metabolism 2017;22(4):219-225
The prevalence of obesity around the world has increased sharply. Strong evidence has emerged over the last decades that human exposure to numerous endocrine disrupting chemicals (EDCs) is the cause of obesity and obesity-related metabolic diseases. Many EDCs are manmade chemicals that are released into the environment. EDCs are exogenous compounds that interfere with hormonal regulation and normal endocrine systems, thereby affecting the health of animals and humans. The number of chemicals belonging to EDCs is increasing and some of them are very stable; they persist in the environment (persistent organic pollutants). Although they are banned, their concentrations have been continuously increasing over time. This review gives a brief introduction to common EDCs, and evidence of harmful effects of EDCs on obesity-related diseases; we focus in particular on EDCs' role in causing mitochondrial dysfunction.
Animals
;
Endocrine Disruptors*
;
Endocrine System
;
Humans
;
Metabolic Diseases
;
Mitochondria
;
Obesity
;
Pediatric Obesity*
;
Prevalence